3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.
Arnost, M., Pierce, A., Haar, E.T., Lauffer, D., Madden, J., Tanner, K., Green, J.(2010) Bioorg Med Chem Lett 20: 1661-1664
- PubMed: 20138514 
- DOI: https://doi.org/10.1016/j.bmcl.2010.01.072
- Primary Citation of Related Structures:  
3L1S - PubMed Abstract: 
A series of 3-aryl-4-(arylhydrazono)-1H-pyrazol-5-one inhibitors of GSK3beta was developed from a low molecular weight, highly ligand efficient screening hit 1. Hit-to-lead optimization led to a number of highly potent inhibitors, while maintaining the high ligand efficiency of the screening hit.
Organizational Affiliation: 
Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA 02139, USA.